Compare HWKN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HWKN | IMNM |
|---|---|---|
| Founded | 1938 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 1995 | 2020 |
| Metric | HWKN | IMNM |
|---|---|---|
| Price | $149.22 | $20.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $200.00 | $32.80 |
| AVG Volume (30 Days) | 97.8K | ★ 935.4K |
| Earning Date | 04-28-2026 | 06-08-2026 |
| Dividend Yield | ★ 0.51% | N/A |
| EPS Growth | 12.26 | ★ 51.40 |
| EPS | ★ 3.17 | N/A |
| Revenue | ★ $974,431,000.00 | $6,941,000.00 |
| Revenue This Year | $12.37 | $18.41 |
| Revenue Next Year | $6.30 | $863.23 |
| P/E Ratio | $47.16 | ★ N/A |
| Revenue Growth | ★ 6.01 | N/A |
| 52 Week Low | $101.19 | $5.15 |
| 52 Week High | $186.15 | $27.65 |
| Indicator | HWKN | IMNM |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 40.30 |
| Support Level | $142.77 | $18.98 |
| Resistance Level | $151.83 | $22.57 |
| Average True Range (ATR) | 4.97 | 1.06 |
| MACD | 0.59 | -0.17 |
| Stochastic Oscillator | 54.72 | 27.44 |
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.